Clinical trials
Recruiting Observational Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 11 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Bristol-Myers Squibb | 2 |
| Dana-Farber Cancer Institute | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Peking University People's Hospital | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| University Health Network, Toronto | 2 |
| University of Rochester | 2 |
| Cancer Support Community, Research and Training Institute, Philadelphia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 44 |
| Leukemia, Myeloid, Acute | 17 |
| Multiple Myeloma | 11 |
| Leukemia | 9 |
| Lymphoma | 8 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Anemia, Aplastic | 6 |
| Neoplasms | 6 |
| Lymphoma, Follicular | 5 |
| Lymphoma, Non-Hodgkin | 5 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.